Your browser doesn't support javascript.
loading
Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy.
Sharma, Gopal; Shah, Milap; Ahluwalia, Puneet; Dasgupta, Prokar; Challacombe, Benjamin J; Bhandari, Mahendra; Ahlawat, Rajesh; Rawal, Sudhir; Buffi, Nicolo M; Sivaraman, Ananthakrishnan; Porter, James R; Rogers, Craig; Mottrie, Alexandre; Abaza, Ronney; Rha, Khoon Ho; Moon, Daniel; Yuvaraja, Thyavihally B; Parekh, Dipen J; Capitanio, Umberto; Maes, Kris K; Porpiglia, Francesco; Turkeri, Levent; Gautam, Gagan.
Afiliación
  • Sharma G; Department of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
  • Shah M; Department of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
  • Ahluwalia P; Department of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India.
  • Dasgupta P; Faculty of Life Sciences and Medicine, King's Health Partners, King's College, London, UK.
  • Challacombe BJ; Guy's and St. Thomas' Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Bhandari M; Vattikuti Foundation, Detroit, MI, USA.
  • Ahlawat R; Medanta - The Medicity Hospital, New Delhi, India.
  • Rawal S; Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Buffi NM; Humanitas Research Hospital, Rozzano, Italy.
  • Sivaraman A; Chennai Urology and Robotics Institute, Chennai, India.
  • Porter JR; Swedish Medical Center, Seattle, WA, USA.
  • Rogers C; Henry Ford Hospital, Detroit, MI, USA.
  • Mottrie A; ORSI Academy, Melle, Belgium.
  • Abaza R; Central Ohio Urology Group and Mount Carmel Health System Prostate Cancer Program, Columbus, OH, USA.
  • Rha KH; Yonsei University Health System, Seoul, South Korea.
  • Moon D; Peter MacCallum Cancer Centre, Royal Melbourne Clinical School, University of Melbourne, Melbourne, Australia.
  • Yuvaraja TB; Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
  • Parekh DJ; University of Miami Health System, Miami, FL, USA.
  • Capitanio U; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Maes KK; Center for Robotic and Minimally Invasive Surgery, Hospital Da Luz, Lisbon, Portugal.
  • Porpiglia F; San Luigi Gonzaga Hospital of Orbassano, Turin, Italy.
  • Turkeri L; Department of Urology, Acibadem M.A, Aydinlar University, Altuzinade Hospital, Istanbul, Turkey.
  • Gautam G; Department of Urologic Oncology, Max Institute of Cancer Care, New Delhi, India. Electronic address: gagangg@gmail.com.
Eur Urol Focus ; 9(2): 345-351, 2023 03.
Article en En | MEDLINE | ID: mdl-36153228
ABSTRACT

BACKGROUND:

Ability to predict the risk of intraoperative adverse events (IOAEs) for patients undergoing partial nephrectomy (PN) can be of great clinical significance.

OBJECTIVE:

To develop and internally validate a preoperative nomogram predicting IOAEs for robot-assisted PN (RAPN). DESIGN, SETTING, AND

PARTICIPANTS:

In this observational study, data for demographic, preoperative, and postoperative variables for patients who underwent RAPN were extracted from the Vattikuti Collective Quality Initiative (VCQI) database. OUTCOME MEASUREMENTS AND STATISTICAL

ANALYSIS:

IOAEs were defined as the occurrence of intraoperative surgical complications, blood transfusion, or conversion to open surgery/radical nephrectomy. Backward stepwise logistic regression analysis was used to identify predictors of IOAEs. The nomogram was validated using bootstrapping, the area under the receiver operating characteristic curve (AUC), and the goodness of fit. Decision curve analysis (DCA) was used to determine the clinical utility of the model. RESULTS AND

LIMITATIONS:

Among the 2114 patients in the study cohort, IOAEs were noted in 158 (7.5%). Multivariable analysis identified five variables as independent predictors of IOAEs RENAL nephrometry score (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.02-1.25); clinical tumor size (OR 1.01, 95% CI 1.001-1.024); PN indication as absolute versus elective (OR 3.9, 95% CI 2.6-5.7) and relative versus elective (OR 4.2, 95% CI 2.2-8); Charlson comorbidity index (OR 1.17, 95% CI 1.05-1.30); and multifocal tumors (OR 8.8, 95% CI 5.4-14.1). A nomogram was developed using these five variables. The model was internally valid on bootstrapping and goodness of fit. The AUC estimated was 0.76 (95% CI 0.72-0.80). DCA revealed that the model was clinically useful at threshold probabilities >5%. Limitations include the lack of external validation and selection bias.

CONCLUSIONS:

We developed and internally validated a nomogram predicting IOAEs during RAPN. PATIENT

SUMMARY:

We developed a preoperative model than can predict complications that might occur during robotic surgery for partial removal of a kidney. Tests showed that our model is fairly accurate and it could be useful in identifying patients with kidney cancer for whom this type of surgery is suitable.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Robótica / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Urol Focus Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Robótica / Procedimientos Quirúrgicos Robotizados / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Urol Focus Año: 2023 Tipo del documento: Article País de afiliación: India
...